Question about a product? Contact one of our experts.   Learn More >
Contact one of our experts.   Learn More >

Questions? Contact Sales:
Contact Us

Cord Blood CD36+ Erythroid Progenitor Cells, Frozen

Questions about shipping? See Shipping Info


Cell differentiation along the erythroid lineage arises from hematopoietic stem cells within cord blood. The cell surface marker CD36, which is considered an early marker of erythrocyte differentiation, is acquired as the differentiation of this lineage progresses. However, the rarity and heterogeneity of the CD36 population make it difficult to isolate in vivo. In order to obtain CD36+ erythroid progenitor cells, CD34+ hematopoietic stem cells (HSC) are isolated and cultured in serum-free expansion media supplemented with factors formulated to promote the expansion and differentiation of human erythroid progenitor cells.

Human cord blood CD36+ erythroid progenitor cells are derived from cultured cord blood CD34+ cells. First, CD34+ cells are positively selected using immunomagnetic anti-CD34 microbeads from the mononuclear cell fraction. The isolated CD34+ cells are cultured in StemSpan™ SFEM, a serum-free expansion media for hematopoietic cells, supplemented with SCF, EPO, and IL-3. Cultured cells are harvested after 10 days. Isolated cells are characterized by flow cytometry prior to cryopreservation to ensure a highly pure and viable cell population.

Cells were obtained using Institutional Review Board (IRB) approved consent forms and protocols.

Additional information





Cell and Tissue Source

Disease State

Donor Attributes

Product Information Sheet

CB CD36 – Frozen

Certificate of Analysis

Sample CoA

Material Safety Data Sheet

Cord Blood – Frozen


Primary Cell Thawing Protocol

Request More Information

Product Interest(Required)
This field is for validation purposes and should be left unchanged.